Insilico Medicine secures $2.75 billion drug collaboration with Eli Lilly

Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market

From OpenAI’s offices to a deal with Eli Lilly — how Chai Discovery became one of the flashiest names in AI drug development

Nvidia, Eli Lilly announce $1 billion investment in AI drug discovery lab